Farid Mozaffari, MD
Plastic Surgery · San Diego, CANPI 1639290075
Payments from drug & device makers
Across 97 payments — averaging $103.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$5K
- Galderma Laboratories, L.p.$1K
- Kls-martin L.p.$985
- Sientra, Inc.$841
- Merz North America, Inc.$787
- Motiva USA, LLC$233
- plus $1K from 14 others
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$500
What the payments were for
- Speaking & faculty fees$2502%
- Travel & lodging$4,34443%
- Food & beverage$5,43754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 17 | $4,976 |
| Galderma Laboratories, L.p. | 33 | $1,063 |
| Kls-martin L.p. | 7 | $985 |
| Sientra, Inc. | 10 | $841 |
| Merz North America, Inc. | 6 | $787 |
| Motiva USA, LLC | 2 | $233 |
| Stryker | 2 | $217 |
| TELA Bio, Inc. | 2 | $214 |
| Mentor Worldwide LLC | 4 | $212 |
| Kerecis Limited | 2 | $160 |
| Integra Lifesciences Corporation | 2 | $139 |
| AbbVie | 2 | $36 |
| Polynovo North America LLC | 1 | $35 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Smith+Nephew | 1 | $22 |
| Apyx Medical Corporation | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dermatology and Wound Care$4,832
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$709
- ADHERUS AUTOSPRAY DURAL SEALANT$174
- SONOPET IQ$174
- Motiva Implant Matrix$167
- SURGIMEND$120
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$114
- Hyalomatrix Wound Device$113
- PluroGel Burn & Wound Dressings$113
- OviTex 2S$100
How this compares
$10,031 in reported general payments places this provider in the 80th percentile of 780 plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $165 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $58 |
| Alprazolam | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in San Diego
- Salvatore PacellaSan Diego$517K
- John ApostolidesSan Diego$460K
- James ChaoSan Diego$328K
- Jason TorantoSan Diego$73K
- Christopher ReidSan Diego$66K
- Rahm NazeraliPalo Alto$1.6M
- Dennis AndersonSan Bernardino$1.3M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$919K
- Anshu GuptaEncinitas$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.